In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ost Developpement SA

Division of Medtronic PLC

Latest From Ost Developpement SA

Osteotech: Bone Better Than Your Own

Using a unique processing technology, Osteotech helped create a market for allograft tissue transplants by increasing availability and improving quality. Riding that technology, Osteotech has gone from providing services to developing products with a line of proprietary allograft tissue, expanding a market in which it remains the leader. While the tissue market is growing and attracting competition from large orthopedic companies, surgeons have been slow in coming around, concerned largely by safety issues similar to those facing blood products. And the specter of a biological solution hovers over the tissue transplant field. Yet, Osteotech remains confident it can continue to grow and fend off major competitors, while expanding internationally and adding spinal implants to the company's tissue products.

Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Medtronic PLC
  • Senior Management
  • Contact Info
  • Ost Developpement SA